Related Experiment Video
Updated: Jul 13, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Pediatric insomnia: a behavioral approach
Mark G Goetting1, Jori Reijonen
1Sleep Health: Comprehensive Sleep Medicine, Portage, MI 49024, USA. mgoetting@gmail.com
Insights
This article reviews behavioral interventions for two common childhood sleep problems: behavioral insomnia of childhood and delayed sleep phase syndrome. Primary care providers can manage these effective behavioral treatments.
Area of Science:
- Pediatric Sleep Medicine
- Behavioral Psychology
Background:
- Insomnia is a prevalent issue in children.
- Common causes include behavioral insomnia of childhood and delayed sleep phase syndrome.
Purpose of the Study:
- To review behavioral interventions for childhood insomnia.
- To provide primary care providers with management strategies for behavioral insomnia of childhood and delayed sleep phase syndrome.
Main Methods:
- Literature review of behavioral interventions for pediatric insomnia.
- Focus on strategies manageable by primary care providers.
Main Results:
- Behavioral interventions are the primary treatment for behavioral insomnia of childhood and delayed sleep phase syndrome.
- These interventions are effective and can be implemented in primary care settings.
Conclusions:
- Primary care providers can effectively manage common childhood insomnia through behavioral interventions.
- Early intervention with behavioral strategies can improve pediatric sleep outcomes.
Abstract:
This article discusses the two common causes of insomnia in children, behavioral insomnia of childhood and delayed sleep phase syndrome. Both of these conditions are primarily treated with behavioral interventions that can be initiated and managed by the primary care provider. A review of these behavioral interventions is provided.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
CNS Depressants: Barbiturates and Benzodiazepines
